Phase III, Randomized, Double Blind Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients.

Trial Profile

Phase III, Randomized, Double Blind Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2012

At a glance

  • Drugs Colecalciferol (Primary)
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Acronyms MelaViD
  • Most Recent Events

    • 02 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 02 Aug 2011 Actual initiation date change from Dec 2010 to May 2010 as reported by ClinicalTrials.gov.
    • 25 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top